Prognostic factors in histopathology of lung cancer

Frontiers of Radiation Therapy and Oncology

Volumn 42, Issue , 2010, Pages 1-14

  Fisseler Eckhoff, Annette ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE M1; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

CANCER SIZE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77949352943     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000262457     Document Type: Review

References (25)

1. Parkin DM,Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer Incidence in Five Continents, vol VIII, IARC Scientific Publications No 155. Lyon, IARC Press, 2002.
2. Flieder DB, Port JL, Korst RJ, Christos PJ, Levin MA, Becker DE, Altorki NK: Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer. Chest 2005;128:2304-2308.
3. TNM Staging System of the International Association for the Study of Lung Cancer, 2009;in press.
4. Huber RM: Lungenkarzinom. Internist (Berl) 2006;47:611-620.
5. Wolf M, Holle R, Hans K, Drings P, Havemann K: Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor of survival. Br J Cancer 1991;63:986-992.
6. Ignatius S-H, Ziogas A, Jason A, Zell DO: Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC). J Thorac Oncol 2009; 4:1.
7. Ceppi P, Longo M, Volante M, Novello S, Cappia S, Bacillo E, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scaliotti G: Excision repair cross complementing-1 and topoisomerase iialpha gene expression in small-cell lung cancer patients treated with platinum and etoposide. J Thorac Oncol 2008; 3:583-589.
8. Simon G, Sharma A, Li X, Hazelton T, Walsh F, Williams CH, Chiappori A, Haura E, Tanvetyanon T, Antonia S, Cantor A, Bepler G: Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer. J Clin Oncol 2007;25:2741-2746.
9. Travis, WD, Brambilla E, Müller-Hermelink HK, Harris CC: Tumours of the lung, pleura, thymus and heart: World Health Organization Classification of Tumours. Lyon, IARC Press, 2004, pp 9-56.
10. Edwards SL, Roberts C, Mc Kean ME, Cockburn JS, Jeffrey RR, Kerr KM: Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category. J Clin Pathol 2000;53:537-540.
11. Roggli VL, Vollmer RT, Greenberg SD, Mc Gavran MH, Spjut HJ, Yesner R: Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985;16:569-579.
12. Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Shirakusa T, Tsuchiya E, Ishikawa Y: Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003:27: 101-109
13. Silver SA, Askin FB: True papillary carcinoma of the lung: a distinct clinicopathologic entity. Am J Surg Pathol 1997;21:43-51.
14. Swinson DE, Jones JL, Richardson D, Cox G, Edwards JG, O'Byrne KJ : Tumor necrosis is months)an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer 2002;37:235-240.
15. Watanabe S, Watanabe T, Arai K, Kasai T, Haratake J, Urayama H: Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002;73:1071-1075.
16. Silvestri GA, Rivera MP: Target therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest 2005;128:3975-3984.
17. Kosaka T, Yatabe Y , Onozato R, Kuwano H, Mitsudomi T : Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol 2009;4:22-29.
18. Massarelli E, Varella-Garcia M, Tang X, Xavier AC, Ozburn NC, Liu DD, Bekele BN, Herbst RS, Wistuba II: KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin Cancer Res 2007;13:2890-2896.
19. Olaussen KA, Dunant A, Fouret P, Brambilla E, André F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, Stahel R, Sabatier L, Pignon JP, Tursz T, Le Chevalier T, Soria JC; IALT Bio Investigators: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355: 983-991.
20. Soria J-C: ERCC1 - tailored chemotherapy in lung cancer: the first prospective randomized trial. J Clin Oncol 2007;25:2648-2649.
21. Shimizu J, Horio Y, Osada H, Hida T, Hasegawa Y, Shimokata K, Takahashi T, Sekido Y, Yatabe Y: mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human cancer cell lines. Respirology 2008;13:510-517.
22. Rosell R, Felip E, Paz-Ares L: How could pharmacogenomics help to improve patient survival? Lung Cancer 2007;57;535-541.
23. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidilate synthase. Cancer 2006;107:1589-1596.
24. Chuang MT, Marchevsky A, Teirstein AS, Kirschner PA, Kleineman J: Diagnosis of lung cancer by fiberoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas. Thorax 1984;39:175-178.
25. Thomas JS, Lamb D, Ashcroft T, Corrin B, Edwards CW, Gibbs AR, Kenyon WE, Stephens RJ, Whimster WF: How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party. Thorax 1992;48:1135-1139.